Literature DB >> 19590180

Continuous hemofiltration in 2009: what is new for clinicians regarding pathophysiology, preferred technique and recommended dose?

P M Honoré1, O Joannes-Boyau, V Collin, W Boer, S Jennes.   

Abstract

In the last years, publications have questioned the classical dose of 35 ml/kg, but are those studies strong enough in terms of scientific power in order to change our practice? We will try to settle some recommendations for clinicians. Manipulation of dose, porosity, and combinations have yielded promising findings. However, conclusive evidence based on randomized trials remains scarce, limiting the practical implementation in daily practice. From the few designed studies, it is safe to say that optimization of delivered dose has a proven positive effect. An ultrafiltration rate of around 35 ml/kg/h, with adjustment for predilution, can be recommended for the septic patient. Recent studies do not have enough power to change this recommendation in view of its shortcomings. Finally the recommendation is to keep going with a continuous technique, a pure continuous veno-venous hemofiltration mode, and at a dose of 35 ml/kg/h while waiting for other studies to be published.

Entities:  

Mesh:

Year:  2009        PMID: 19590180     DOI: 10.1159/000227282

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  4 in total

1.  Septic acute kidney injury and tubular apoptosis: never a Lone Ranger.

Authors:  Olivier Joannes-Boyau; Patrick M Honoré; Willem Boer; Thomas Rose
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

2.  Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis.

Authors:  Zhi-Yong Peng; Hong-Zhi Wang; Melinda J Carter; Morgan V Dileo; Jeffery V Bishop; Fei-Hu Zhou; Xiao-Yan Wen; Thomas Rimmelé; Kai Singbartl; William J Federspiel; Gilles Clermont; John A Kellum
Journal:  Kidney Int       Date:  2011-09-14       Impact factor: 10.612

3.  Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments.

Authors:  Patrick M Honore; Rita Jacobs; Olivier Joannes-Boyau; Jouke De Regt; Willem Boer; Elisabeth De Waele; Vincent Collin; Herbert D Spapen
Journal:  Ann Intensive Care       Date:  2011-08-09       Impact factor: 6.925

4.  Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: key potential role of hemoadsorption elimination during continuous venovenous hemofiltration.

Authors:  Patrick M Honore; Rita Jacobs; Stijn Lochy; Elisabeth De Waele; Viola Van Gorp; Jouke De Regt; Geert Martens; Olivier Joannes-Boyau; Willem Boer; Herbert D Spapen
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.